⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,136.44
−0.11%
Brent
$109.22
−0.54%
BTC
$81,980.23
−0.04%
ETH
$2,404.15
−0.13%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,136.44
−0.11%
Brent
$109.22
−0.54%
BTC
$81,980.23
−0.04%
ETH
$2,404.15
−0.13%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NYSE
› ABBV
A
AbbVie Inc
NYSE:ABBV
Healthcare
CBOE:SPESG
NASDAQ:NQUSLG
$282.68
−0.96%
At close
At close · Tue 20 Oct · ≈
AED 1,038.14
· Market cap
$499.53B
· Next earnings
Fri 30 Oct
· Extended
$282.61
−0.02%
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
ABBV news
Headlines tagged to this company
RE
Pharma sector doubles down on AI to slash costs, timelines
Reuters · 9 h ago
RE
Major drugmakers turn to China for licensing deals
Reuters · 9 h ago
DP
AbbVie's Dual-Targeting Therapy Shows Higher Remission Rates In Mid-Stage Crohn's Disease Study
dpa-AFX · 14 h ago
SE
Goldman's defensive stocks with quality-growth characteristics
Seeking Alpha · 32 h ago
SE
Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus
Seeking Alpha · 34 h ago
RE
Abbvie Says Risankizumab In Ulcerative Colitis Shows Clinical Remission Rates Of 54.0%-73.1% At Week 96
Reuters · 3 d ago
RE
AbbVie - Expands Board To Thirteen Directors On October 14, 2026 - SEC Filing
Reuters · 4 d ago
TR
AbbVie appoints Dr. John M. Carethers to its Board as Class II director
TradingView · 4 d ago
MA
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
MarketWatch · 4 d ago
SE
Nvidia-backed drug discovery firm Iambic climbs on trading debut
Seeking Alpha · 4 d ago
DO
Lilly, Merck, AbbVie Stocks Surge. Why Healthcare Is Rallying Today. — Barrons.com
Dow Jones Newswires · 5 d ago
DO
Here's What to Buy After Hot CPI Puts an October Fed Rate Hike Back on the Table — Barrons.com
Dow Jones Newswires · 5 d ago
DP
AbbVie's Subcutaneous Skyrizi Shows Endoscopic Benefits In Crohn's Diseases
dpa-AFX · 6 d ago
SE
AbbVie releases phase 3 induction therapy data on injectable Skyrizi for Crohn's
Seeking Alpha · 6 d ago
DO
Abbvie's Crohn's Disease Drug Skyrizi Shows More Positive Results
Dow Jones Newswires · 6 d ago
DO
AbbVie Price Target Maintained With a $280.00/Share by RBC Capital
Dow Jones Newswires · 6 d ago
TR
RBC Capital reiterates Outperform rating on AbbVie, $280 price target
TradingView · 6 d ago
SE
AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades
Seeking Alpha · 7 d ago
More news →
AbbVie Inc · News · TradingHolo